openPR Logo
Press release

Global Treatment-Resistance Depression Treatment Market Growth during the Forecast Period, 2018-2028 // Forest Laboratories (Allergan plc), Janssen Pharmaceuticals, Inc., Schering Plough Corporation, Vistagen Therapeutics, Inc

05-07-2019 11:49 AM CET | Health & Medicine

Press release from: Fact.MR

Global Treatment-Resistance Depression Treatment Market

This rising prevalence of treatment-resistance depression treatment will boost the market for the Treatment-Resistance Depression Treatment Market. It has been observed that a few populations with treatment-resistance depression treatment showed the response to initial antidepressant without side effects. However, a combination of antidepressant medication and certain types of therapy have the potential risk for harmful drug interactions and side effects and may increase the healthcare cost. This may restrain the growth of the treatment-resistance depression treatment market.

Request TOC of this Report- https://www.factmr.com/connectus/sample?flag=T&rep_id=3147

The depression which does not respond or shows any sign of improvement when treated with an antidepressant is known as a treatment-resistance depression treatment. In several American and European countries, the prevalence of treatment-resistance depression treatment is high and are prevalent in the 40 to 60 age group of the population. The treatment-resistance depression treatment is high in female as compared to that in the male. At present, the female population has a high disease burden for treatment-resistance depression treatment accounting for almost twice as that is the male population group. According to the treatment providers, patients with treatment-resistance depression treatment are found to be twice as those with depressive disorder. The hospitalized rate is high in the population with treatment-resistance depression treatment. Thus, the hospitalized cost burden is 5-6 times higher than those with major depressive disorder. Consequently, the treatment-resistance depression treatment is the most neglected and a major public health issue which is rising at a high rate, worldwide.

Treatment-Resistance Depression Treatment: Market Dynamics

The increasing prevalence of depression and anxiety-related disorders in adults, as well as the aging population, is the major factor contributing to the growth of treatment-resistance depression treatment market. The estimated prevalence for stage 1 treatment-resistance depression treatment is around 2-3% and for stage 2 treatment-resistance depression treatment population the prevalence is estimated to be 1.5-2%, worldwide. The rising geriatric population is also one of the factors that propelled the growth of treatment-resistance depression treatment market because the treatment-resistance depression treatment is high in this age group population. However, the continuous patent expiration of major antidepressants may hamper the growth of the treatment-resistance depression treatment market. Additionally, low acceptance of mental disorders in developing regions may hamper the growth of treatment-resistance depression treatment market.

Browse Full Report with TOC- https://www.factmr.com/report/3147/treatment-resistance-depression-treatment-market 

The growing population with the depression-related disorder, rapid technological innovations, and rising medical applications will boost the treatment-resistance depression treatment market across the globe and is expected to show high revenue growth over the forecast period. Also, the high acceptance rate for mentally disorder, depression and anxiety, especially in developed regions will boost the treatment-resistant depression treatment market. Also, initiatives by government and other NGOs are expected to increase the awareness in the population regarding treatment-resistance depression treatment options and may boost the market in developed and developing regions.

Treatment-Resistance Depression Treatment market: Region-wise Outlook

North America is expected to show the highest revenue growth and to hold the largest market shares in the global treatment-resistance depression treatment market due to advanced healthcare infrastructure and healthcare spending. Additionally, increasing the adoption rate and demand will boost the treatment-resistance depression treatment market in this region, followed by Europe. The treatment-resistance depression treatment market in the Asia-Pacific region is expected to register the moderate growth due to low acceptance and high negligence rate for mental disorders and depression. Whereas, Latin America and the Middle East & Africa are expected to show stagnant treatment-resistance depression treatment market growth due to weak healthcare management for mentally disorder, depression and anxiety related disorders and low awareness.

Treatment-Resistance Depression Treatment market: Key Players

Some of the key players present in global treatment-resistance depression treatment market are AstraZeneca plc, Pfizer, Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb, Forest Laboratories (Allergan plc), Janssen Pharmaceuticals, Inc., Schering Plough Corporation, Vistagen Therapeutics, Inc., Wyeth and others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=3147

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Treatment-Resistance Depression Treatment Market Growth during the Forecast Period, 2018-2028 // Forest Laboratories (Allergan plc), Janssen Pharmaceuticals, Inc., Schering Plough Corporation, Vistagen Therapeutics, Inc here

News-ID: 1729627 • Views:

More Releases from Fact.MR

Kids Bicycle Market Set for Remarkable Growth, Expected to Surpass US$ 29.64 Billion by 2033 at 4.7% CAGR
04-19-2024 | Sports
Fact.MR
Kids Bicycle Market Set for Remarkable Growth, Expected to Surpass US$ 29.64 Bil …
By 2023, the kids bicycle market is projected to be valued at US$ 18.7 billion, and by 2033, it is anticipated to grow at a compound annual growth rate (CAGR) of 4.7% to reach US$ 29.64 billion. By the end of 2023, sales of children's bicycles are predicted to make up over 37% of the worldwide bicycle market. A positive shift in the demand for bicycles has been attributed to a
U.S. Population Health Management (PHM) Solutions Market Set to Hit US$ 34.59 Billion by 2028 | Fact.MR
04-19-2024 | Health & Medicine
Fact.MR
U.S. Population Health Management (PHM) Solutions Market Set to Hit US$ 34.59 Bi …
The global market for population health management (PHM) solutions in the United States is expected to expand at a compound annual growth rate (CAGR) of 14.8% between 2021 and 2028, according to a recently released Fact.MR analysis. By the end of 2028, the market is projected to reach US$ 34.59 billion. Over the projected period, there is anticipated to be an increase in demand for U.S. Population Health Management (PHM)
Bleaching Clay Market is Anticipated to Grow at a CAGR of 7.2% to Top US$ 1.86 Billion by 2032
Bleaching Clay Market is Anticipated to Grow at a CAGR of 7.2% to Top US$ 1.86 B …
The bleaching clay market was valued at US$ 932.2 million in 2022. Moreover, growth is anticipated to pick up speed at a robust 7.2% CAGR during the evaluation period of 2022-2032, culminating in US$ 1.86 billion. Bleaching clay has been widely utilized for edible oil purification since the nineteenth century. Variations in the yield of oilseed crops are anticipated to positively affect the global market for bleaching clay since bleaching
Automated Microscopy Market to Reach US$ 8.5 Billion by 2027, Grow at a CAGR of 7.5%: Fact.MR
04-19-2024 | Health & Medicine
Fact.MR
Automated Microscopy Market to Reach US$ 8.5 Billion by 2027, Grow at a CAGR of …
According to the most recent analysis conducted by market research and competitive intelligence company Fact.MR, the automated microscopy market is expected to be valued US$ 8.5 billion globally by 2027. With the use of sophisticated monitoring techniques, automated microscopy is a contemporary technology that enhances the monitoring of biological material. In addition to reducing human error, automated microscopy offers accurate, automated magnification for topic examination and analysis. Because automated microscopy is

All 5 Releases


More Releases for Treatment

Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking